Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Treasury Shares: 2009-2025

Historic Treasury Shares for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Sep 2025 value amounting to $4.3 billion.

  • UNITED THERAPEUTICS's Treasury Shares rose 22.64% to $4.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 billion, marking a year-over-year increase of 22.64%. This contributed to the annual value of $3.5 billion for FY2024, which is 34.71% up from last year.
  • According to the latest figures from Q3 2025, UNITED THERAPEUTICS's Treasury Shares is $32.8 million, which was up 8.75% from $30.2 million recorded in Q2 2025.
  • In the past 5 years, UNITED THERAPEUTICS's Treasury Shares ranged from a high of $32.8 million in Q3 2025 and a low of $181,772 during Q2 2024.
  • Its 3-year average for Treasury Shares is $23.9 million, with a median of $26.6 million in 2023.
  • Data for UNITED THERAPEUTICS's Treasury Shares shows a peak YoY spiked of 34.74% (in 2024) over the last 5 years.
  • UNITED THERAPEUTICS's Treasury Shares (Quarterly) stood at $2.6 billion in 2021, then remained steady at $2.6 billion in 2022, then remained steady at $2.6 billion in 2023, then surged by 34.71% to $3.5 billion in 2024, then climbed by 22.64% to $4.3 billion in 2025.
  • Its Treasury Shares was $4.3 billion in Q3 2025, compared to $3.5 billion in Q2 2025 and $3.5 billion in Q1 2025.